secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pluri Inc. (PLUR)
CIK:        0001158780
Form:       8-K
Filed at:   2026-10-30T12:30:28+00:00
Accession:  0001213900-26-114079
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4.1-flash:cloud@v2

Pluri to take 50% stake in ZEO ScientifiX via exclusive regenerative-medicine license; raises $1M at $1.10/share
--------------------------------------------------------------------------------

- Pluri grants ZEO an exclusive U.S. license to manufacture and commercialize its regenerative medicine portfolio (aesthetics/skin care excluded), expandable to Latin America.
- Consideration: 41% of ZEO shares plus 50 Series D preferred shares carrying 51% of ZEO votes; cross-share swaps lift Pluri to 50% of ZEO with 4 of 7 board seats.
- Five-year ZEO warrants for 5% at $4.00/share and 2.5% at $5.50/share, plus another 5% if ZEO's 10-day VWAP reaches $5.50; closing due within 90 days of Oct 26, 2026.
- Separate Oct 27 purchase agreements: two investors buy 909,092 PLUR shares at $1.10 plus 909,092 warrants at $1.30, for $1.0M total, closing by Oct 30, 2026.
- EIB sold its ~$27.5M Pluri loan (disbursed €20M tranche at 4%, due June 1, 2026) to Chutzpah Holdings, owned by chairman Alexandre Weinstein; settlement terms not yet agreed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1158780/000121390026114079/0001213900-26-114079-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1158780/000121390026114079/ea0310259-8k_pluri.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-114079

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer